3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
16
Myelodysplastic Syndromes
9
Lung Neoplasms
5
Myeloproliferative Disorders
4
Leukemia, Myelomonocytic, Chronic
4
Sarcoma
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Head and Neck Neoplasms
3
Breast Neoplasms
3
Stomatitis
2
Primary Myelofibrosis
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Mucositis
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Leukemia, Monocytic, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Biphenotypic, Acute
2
Disease
2
Carcinoma, Non-Small-Cell Lung
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Synovial
1
Prostate Cancer Metastatic
1
Polycythemia Vera
1
Interventions
Temozolomide
53
Bevacizumab
45
Radiotherapy
28
Radiosurgery
21
Carboplatin
14
Erlotinib Hydrochloride
11
Radiation
10
Magnetic Resonance Spectroscopy
9
Etoposide
9
pembrolizumab
8
Vorinostat
8
Trastuzumab
8
Irinotecan
8
Sunitinib
7
Sorafenib
7
Radiotherapy, Intensity-Modulated
7
Lomustine
7
Lapatinib
7
Capecitabine
7
dabrafenib
6
Ipilimumab
6
Imatinib Mesylate
6
Cyclophosphamide
6
Sirolimus
5
Hydroxyurea
5
Everolimus
5
Bortezomib
5
temsirolimus
4
cabozantinib
4
binimetinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Brain Neoplasms
×
Injections
×
Clear all
No trials found.